27 August 2020
Dr Andrea Srur, Programme Manager for the national Diabetes Quality Programme, describes the recent successes from this project and the challenges presented by the COVID-19 outbreak.
1 August 2020
We look ahead to plans for digital growth charts, which will be available to parents and carers in 2021.
9 July 2020
After the success of past Academic Trainees Days, we have started preparations for hosting the 2020 event in late October. Due to the uncertainties around COVID-19, we'll be holding it online. As always, you'll hear from those working in child health research and have opportunities for networking.
26 June 2020
Ranitidine products (Brand names including Zantac®) were voluntarily withdrawn by manufacturers in October 2019, because of fears that they may contain low levels of an impurity called NMDA.
13 March 2020
Russell updates members on how the College is responding to COVID-19. In this message, which has been emailed to all members, he outlines the College's actions towards COVID-19 and highlights advice and guidance for our members.
12 March 2020
The National Paediatric Diabetes Audit (NDPA) 2018/19 Annual Report on Care Processes and Outcomes was published today by the Royal College of Paediatrics and Child Health (RCPCH).
4 March 2020
The RCPCH has today published State of Child Health 2020, the largest ever compilation of data on the health of babies, children and young people across all four UK nations. The report shows that for many measures of children’s health and wellbeing, progress has stalled, or is in reverse – something...
19 February 2020
Russell has been speaking with quite a few members about COVID-19, also known as the novel coronavirus. In this message, which has been emailed to all members, he outlines what we know and how the situation is affecting the RCPCH.
3 February 2020
NHSE is conducting a review of the specification for this service and associated policies for 2020. It will also set up an independent expert group to make recommendations regarding the use of puberty suppressants and cross-sex hormones.
16 December 2019
Domperidone is no longer licensed for use in children younger than 12 years or those weighing less than 35 kg because of a lack of evidence for benefit.